Roche gets boost from FDA in bid to expand uses for Actemra

ZURICH (Reuters) - The U.S. Food and Drug Administration has granted breakthrough status to Roche's rheumatoid arthritis medication Actemra for giant cell arteritis, the Swiss drugmaker said, a step which could help it broaden applications for the medicine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news